You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Grade III Glioma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma Trial in San

Recruiting
  • Recurrent World Health Organization (WHO) Grade II Glioma
  • +3 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Dec 21, 2022

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

    Withdrawn
    • Recurrent Anaplastic Astrocytoma
    • +7 more
    • Neural Stem Cells-expressing CRAd-S-pk7
    • Resection
    • (no location specified)
    Nov 22, 2022

    High Grade Glioma, Glioblastoma Trial in Cleveland (Standard Surgical Treatment, Intraoperative Electrocorticography)

    Not yet recruiting
    • High Grade Glioma
    • Glioblastoma
    • Standard Surgical Treatment
    • Intraoperative Electrocorticography
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Sep 30, 2022

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    Intracranial Tumor, Low Grade Glioma, Recurrent Glioblastoma Trial in San Francisco (F-18 Fluoroethyltyrosine (FET), Positron

    Recruiting
    • Intracranial Neoplasm
    • +4 more
    • F-18 Fluoroethyltyrosine (FET)
    • Positron Emission Tomography (PET)
    • San Francisco, California
      University of California, San Francisco
    Nov 7, 2022

    Glioblastoma, Recurrent Adult Brain Tumor, Malignant Glioma Trial in Richmond (sorafenib tosylate, valproic acid, sildenafil

    Active, not recruiting
    Has Results
    • Glioblastoma
    • +3 more
    • sorafenib tosylate
    • +2 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    Mar 21, 2022

    Glioblastoma, Malignant Glioma, Recurrent Glioblastoma Trial in Worldwide (biological, drug, other)

    Recruiting
    • Glioblastoma
    • +5 more
    • Ipilimumab
    • +4 more
    • Birmingham, Alabama
    • +19 more
    Aug 16, 2022

    High Grade Glioma, Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma Trial in Worldwide (Ribociclib, Everolimus)

    Not yet recruiting
    • High Grade Glioma
    • +8 more
    • Aurora, Colorado
    • +17 more
    May 2, 2023

    Grade III or Grade IV Glioma Trial (PET imaging with 18F fluciclovine)

    Not yet recruiting
    • Grade III or Grade IV Glioma
    • PET imaging with 18F fluciclovine
    • (no location specified)
    Jul 27, 2022

    Glioblastoma, Low Grade Glioma, Malignant Glioma Trial in Houston (Mind-Body Intervention Procedure, Quality-of-Life Assessment,

    Completed
    • Glioblastoma
    • +5 more
    • Mind-Body Intervention Procedure
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 8, 2021

    Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

    Active, not recruiting
    • Recurrent Anaplastic Astrocytoma
    • +6 more
    • Carboxylesterase-expressing Allogeneic Neural Stem Cells
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jun 7, 2022

    Supramaximal Resection Versus Maximal Resection for High-Grade

    Recruiting
    • Glioblastoma
    • +11 more
    • Supramaximal resection
    • Maximal safe resection
    • San Francisco, California
    • +7 more
    Nov 1, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    Has Results
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Glioma of Brain Trial in Bern, Lausanne, Zürich (L19TNF)

    Active, not recruiting
    • Glioma of Brain
    • Bern, Switzerland
    • +2 more
    Apr 7, 2022

    Glioblastoma, WHO Grade II Glioma, WHO Grade III Glioma Trial in Philadelphia (Intensity-Modulated Radiation Therapy,

    Recruiting
    • Glioblastoma
    • +2 more
    • Intensity-Modulated Radiation Therapy
    • Quality-of-Life
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jun 3, 2021

    Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

    Recruiting
    • Diffuse Midline Glioma (DMG)
    • +7 more
    • ONC206
    • Standard of Care Radiation Therapy
    • San Francisco, California
    • +2 more
    Sep 13, 2022

    High Grade Glioma Trial in Basel (endurance training, social support and counseling, resistance training)

    Completed
    • High Grade Glioma
    • endurance training
    • +2 more
    • Basel, Switzerland
    • +1 more
    May 17, 2022

    Recurrent Glioblastoma, Recurrent Malignant Glioma, Recurrent WHO Grade II Glioma Trial in Duarte (Chlorotoxin

    Recruiting
    • Recurrent Glioblastoma
    • +3 more
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT delivery)
    • Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes (via ICT/ICV dual delivery)
    • Duarte, California
      City of Hope Medical Center
    Feb 25, 2022

    Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Stereotactic Radiosurgery
    • Lake Success, New York
      Northwell Health Brain Tumor Center
    Feb 3, 2022

    Molecular Phenotype and Radiological Signature of Incident WHO

    Enrolling by invitation
    • Glioma
    • Retrospective analysis
    • Marseille, France
      Hôpital Privé Clairval
    Aug 16, 2021

    Grade II Glioma, Grade III Glioma, Grade IV Glioma Trial in Boston (Microdevice)

    Recruiting
    • Grade II Glioma
    • +7 more
    • Microdevice
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Feb 22, 2021

    Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

    Not yet recruiting
    • Advanced Solid Tumor
    • +2 more
    • Palo Alto, California
    • +9 more
    Aug 2, 2022

    Glioblastoma, Malignant Glioma, WHO Grade III Glioma Trial in Scottsdale (Palliative Therapy, Quality-of-Life Assessment,

    Completed
    • Glioblastoma
    • +2 more
    • Palliative Therapy
    • +3 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Nov 24, 2020

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022